Health
Altering balance of fibroblasts could prevent spread of colorectal cancer – Drug Target Review
Researchers found colorectal cancer-associated fibroblasts can be altered with a gremlin 1-neutralising antibody or overexpressing meflin.
Posted: 1 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found that colorectal cancer-associated fibroblasts can be altered using a gremlin 1-neutralising antibody or by overexpressing meflin.
Researchers have revealed that colorectal cancer tissues contain at least two types of fibroblasts – cancer-promoting fibroblasts and cancer-restraining fibroblasts. The team, from Nagoya University, Japan, found that the balance between the two is largely involved in…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General13 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News17 hours agoBrisbane rising on global rankings, but still behind southern capitals